Annual Accounts Receivable
$837.27 M
+$132.37 M+18.78%
30 June 2024
Summary:
ResMed annual accounts receivable is currently $837.27 million, with the most recent change of +$132.37 million (+18.78%) on 30 June 2024. During the last 3 years, it has risen by +$222.98 million (+36.30%). RMD annual accounts receivable is now at all-time high.RMD Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$811.20 M
-$26.08 M-3.11%
30 September 2024
Summary:
ResMed quarterly accounts receivable is currently $811.20 million, with the most recent change of -$26.08 million (-3.11%) on 30 September 2024. Over the past year, it has increased by +$118.81 million (+17.16%). RMD quarterly accounts receivable is now -3.11% below its all-time high of $837.27 million, reached on 30 June 2024.RMD Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RMD Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.8% | +17.2% |
| 3 y3 years | +36.3% | +40.9% |
| 5 y5 years | +58.4% | +64.3% |
RMD Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +45.4% | -3.1% | +59.5% |
| 5 y | 5 years | at high | +76.4% | -3.1% | +74.5% |
| alltime | all time | at high | +2496.4% | -3.1% | +2415.5% |
ResMed Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $811.20 M(-3.1%) |
| June 2024 | $837.27 M(+18.8%) | $837.27 M(+7.4%) |
| Mar 2024 | - | $779.26 M(+6.8%) |
| Dec 2023 | - | $729.74 M(+5.4%) |
| Sept 2023 | - | $692.39 M(-1.8%) |
| June 2023 | $704.91 M(+22.4%) | $704.91 M(+2.7%) |
| Mar 2023 | - | $686.26 M(+2.1%) |
| Dec 2022 | - | $672.27 M(+8.3%) |
| Sept 2022 | - | $620.48 M(+7.7%) |
| June 2022 | $575.95 M(-6.2%) | $575.95 M(+13.2%) |
| Mar 2022 | - | $508.58 M(-3.3%) |
| Dec 2021 | - | $526.04 M(-8.6%) |
| Sept 2021 | - | $575.55 M(-6.3%) |
| June 2021 | $614.29 M(+29.4%) | $614.29 M(+17.0%) |
| Mar 2021 | - | $525.01 M(+3.1%) |
| Dec 2020 | - | $509.36 M(+9.6%) |
| Sept 2020 | - | $464.89 M(-2.1%) |
| June 2020 | $474.64 M(-10.2%) | $474.64 M(-14.5%) |
| Mar 2020 | - | $554.86 M(+5.1%) |
| Dec 2019 | - | $528.04 M(+6.9%) |
| Sept 2019 | - | $493.84 M(-6.6%) |
| June 2019 | $528.48 M(+9.3%) | $528.48 M(+3.3%) |
| Mar 2019 | - | $511.40 M(+7.2%) |
| Dec 2018 | - | $477.19 M(+2.9%) |
| Sept 2018 | - | $463.74 M(-4.1%) |
| June 2018 | $483.68 M(+7.4%) | $483.68 M(-3.0%) |
| Mar 2018 | - | $498.43 M(+3.2%) |
| Dec 2017 | - | $482.93 M(+12.0%) |
| Sept 2017 | - | $431.35 M(-4.3%) |
| June 2017 | $450.53 M(+17.9%) | $450.53 M(+8.9%) |
| Mar 2017 | - | $413.61 M(+7.7%) |
| Dec 2016 | - | $383.99 M(+10.6%) |
| Sept 2016 | - | $347.14 M(-9.1%) |
| June 2016 | $382.09 M(+5.4%) | $382.09 M(+6.7%) |
| Mar 2016 | - | $358.17 M(+8.0%) |
| Dec 2015 | - | $331.75 M(+1.4%) |
| Sept 2015 | - | $327.17 M(-9.8%) |
| June 2015 | $362.57 M(+0.8%) | $362.57 M(+4.9%) |
| Mar 2015 | - | $345.49 M(+1.5%) |
| Dec 2014 | - | $340.43 M(+3.6%) |
| Sept 2014 | - | $328.59 M(-8.6%) |
| June 2014 | $359.59 M(+13.0%) | $359.59 M(+6.5%) |
| Mar 2014 | - | $337.57 M(+11.9%) |
| Dec 2013 | - | $301.63 M(+6.8%) |
| Sept 2013 | - | $282.43 M(-11.3%) |
| June 2013 | $318.35 M | $318.35 M(+8.5%) |
| Mar 2013 | - | $293.49 M(+4.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | - | $281.44 M(+5.6%) |
| Sept 2012 | - | $266.54 M(-5.9%) |
| June 2012 | $283.16 M(+3.2%) | $283.16 M(+5.7%) |
| Mar 2012 | - | $267.93 M(+12.2%) |
| Dec 2011 | - | $238.76 M(-4.9%) |
| Sept 2011 | - | $251.10 M(-8.5%) |
| June 2011 | $274.35 M(+20.9%) | $274.35 M(+8.9%) |
| Mar 2011 | - | $251.94 M(+7.2%) |
| Dec 2010 | - | $235.08 M(+4.1%) |
| Sept 2010 | - | $225.84 M(-0.5%) |
| June 2010 | $226.91 M(+7.0%) | $226.91 M(+1.4%) |
| Mar 2010 | - | $223.67 M(+7.0%) |
| Dec 2009 | - | $208.95 M(+0.1%) |
| Sept 2009 | - | $208.82 M(-1.5%) |
| June 2009 | $212.10 M(+10.4%) | $212.10 M(+8.2%) |
| Mar 2009 | - | $195.99 M(+5.5%) |
| Dec 2008 | - | $185.73 M(+5.6%) |
| Sept 2008 | - | $175.83 M(-8.5%) |
| June 2008 | $192.20 M(+14.5%) | $192.20 M(+6.9%) |
| Mar 2008 | - | $179.87 M(+5.3%) |
| Dec 2007 | - | $170.77 M(+2.6%) |
| Sept 2007 | - | $166.42 M(-0.8%) |
| June 2007 | $167.82 M(+21.5%) | $167.82 M(+9.6%) |
| Mar 2007 | - | $153.06 M(+6.6%) |
| Dec 2006 | - | $143.60 M(+10.5%) |
| Sept 2006 | - | $129.91 M(-6.0%) |
| June 2006 | $138.15 M(+32.9%) | $138.15 M(+8.6%) |
| Mar 2006 | - | $127.18 M(+10.2%) |
| Dec 2005 | - | $115.37 M(+12.0%) |
| Sept 2005 | - | $102.99 M(-0.9%) |
| June 2005 | $103.95 M(+54.6%) | $103.95 M(+16.7%) |
| Mar 2005 | - | $89.11 M(+15.9%) |
| Dec 2004 | - | $76.86 M(+11.8%) |
| Sept 2004 | - | $68.75 M(+2.2%) |
| June 2004 | $67.24 M(+18.6%) | $67.24 M(+2.0%) |
| Mar 2004 | - | $65.93 M(+13.4%) |
| Dec 2003 | - | $58.16 M(+3.9%) |
| Sept 2003 | - | $55.96 M(-1.3%) |
| June 2003 | $56.69 M(+22.7%) | $56.69 M(+7.7%) |
| Mar 2003 | - | $52.64 M(+6.9%) |
| Dec 2002 | - | $49.24 M(+5.5%) |
| Sept 2002 | - | $46.70 M(+1.1%) |
| June 2002 | $46.20 M(+43.3%) | $46.20 M(+5.1%) |
| Mar 2002 | - | $43.97 M(+19.4%) |
| Dec 2001 | - | $36.82 M(+9.9%) |
| Sept 2001 | - | $33.50 M(+3.9%) |
| June 2001 | $32.25 M | $32.25 M(-2.5%) |
| Mar 2001 | - | $33.08 M |
FAQ
- What is ResMed annual accounts receivable?
- What is the all time high annual accounts receivable for ResMed?
- What is ResMed annual accounts receivable year-on-year change?
- What is ResMed quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for ResMed?
- What is ResMed quarterly accounts receivable year-on-year change?
What is ResMed annual accounts receivable?
The current annual accounts receivable of RMD is $837.27 M
What is the all time high annual accounts receivable for ResMed?
ResMed all-time high annual accounts receivable is $837.27 M
What is ResMed annual accounts receivable year-on-year change?
Over the past year, RMD annual accounts receivable has changed by +$132.37 M (+18.78%)
What is ResMed quarterly accounts receivable?
The current quarterly accounts receivable of RMD is $811.20 M
What is the all time high quarterly accounts receivable for ResMed?
ResMed all-time high quarterly accounts receivable is $837.27 M
What is ResMed quarterly accounts receivable year-on-year change?
Over the past year, RMD quarterly accounts receivable has changed by +$118.81 M (+17.16%)